Opinion

Video

The Role of BTK Inhibitors in the Evolving CSU Treatment Landscape

Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors are reshaping the evolving treatment landscape for chronic spontaneous urticaria (CSU) by providing targeted therapeutic options that address underlying mast cell activation.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.